Fluoxetine plus insight meditation therapy for an SLE patient with depressive disorder: a two-year follow-up

Treatment of SLE with comorbid mood disorder is relatively challenging. We report the improvement of both disease activity and mood symptoms in a female patient treated with fluoxetine and insight-meditation therapy (IMT). Her clinical and mood symptoms, assessed with the Hamilton Rating Scale for Depression (HAM-D) and the Hamilton Anxiety Rating Scale (HAM-A), improved continuously and both went down from 33 and 26 to 3 and 0 within 2 years of the combination treatment. Psychological distress in SLE may be a condition which responds well to fluoxetine and insight-meditation